Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer

Genes Chromosomes and Cancer

Volumn 43, Issue 2, 2005, Pages 162-171

  Nakano, Tetsuhiro ^a,b   Tani, Masachika ^a   Nishioka, Michiho ^a   Kohno, Takashi ^a   Otsuka, Ayaka ^a   Ohwada, Susumu ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HISTONE H3; HISTONE H4; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL LINE; CHROMOSOME 22Q; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DEACETYLATION; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; METHYLATION; MYO18B GENE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ACETYLATION; AZACITIDINE; BASE SEQUENCE; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 22; COLORECTAL NEOPLASMS; DNA PRIMERS; HUMANS; IMMUNOPRECIPITATION; MUTATION; MYOSINS; TUMOR SUPPRESSOR PROTEINS;

EID: 17644367505     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20180     Document Type: Article

References (34)

1. Baeg GH, Matsumine A, Kuroda T, Bhattacharjee RN, Miyashiro I, Toyoshima K, Akiyama T. 1995. The tumor suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBOJ 14:5618-5625.
2. Balmain A, Gray J, Ponder B. 2003. The genetics and genomics of cancer. Nat Genet 33(Suppl):238-244.
3. Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK. 1999. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology 117:831-837.
4. Dai JL, Bansal RK, Kern SE. 1999. G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. Proc Natl Acad Sci USA 96:1427-1432.
5. Duriez C, Schmitz A, Fouchet P, Buecher B, Thuille B, Lerebours F, Leger R, Boman F, Flejou JF, Monges G, Paraf F, Bedossa P, Sabourin JC, Salmon RJ, Laurent-Puig P, Thomas G.Olschwang S. 1997. Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers. Gastroenterol Clin Biol 21:358-364.
6. Evans DG, Sainio M, Baser ME. 2000. Neurofibromatosis type 2. J Med Genet 37:897-904.
7. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
8. Fodde R, Smits R, Clevers H. 2001. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1:55-67.
9. Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JD, Ponder BA, Kouzarides T, Caldas C. 2000. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24:300-303.
10. Groden J, Joslyn G, Samowitz W, Jones D, Bhattacharyya N, Spirio L, Thliveris A, Robertson M, Egan S, Meuth M. 1995. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55:1531-1539.
11. Iino H, Fukayama M, Maeda Y, Koike M, Mori T, Takahashi T, Kikuchi-Yanoshita R, Miyaki M, Mizuno S, Watanabe S. 1994. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer 73:1324-1331.
12. Ionov Y, Nowak N, Perucho M, Markowitz S, Cowell JK. 2004. Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogene 23:639-645.
13. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245-254.
14. Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M. 2002. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res 30:4770-4780.
15. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. 2000. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 14:1319-1331.
16. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA, Steeg PS. 1991. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35.
17. Leone A, Flatow U, VanHoutte K, Steeg PS. 1993. Transaction of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8:2325-2333.
18. Lim S, Lee HY, Lee H. 1998. Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. Cancer Lett 133:143-149.
19. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, Kikuchi R, Iwama T, Ikeuchi T, Tonomura A. 1990. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 50:7166-7173.
20. Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T, Miyaki M. 1996. p300 Gene alterations in colorectal and gastric carcinomas. Oncogene 12:1565-1569.
21. Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB, Imaizumi N, Tsuda H, Aoyagi K, Sasaki H, Ohwada S, Yokota J. 2003. Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 20:665-674.
22. Nakao K, Shibusawa M, Ishihara A, Yoshizawa H, Tsunoda A, Kusano M, Kurose A, Makita T, Sasaki K. 2001. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91:721-726.
23. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA. 2002. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′- deoxycytidine. Cancer Res 62:6456-6461.
24. Nishioka M, Kohno T, Takahashi M, Niki T, Yamada T, Sone S, Yokota J. 2000. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line. Oncogene 19:6251-6260.
25. Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minnna JD, Sone S, Yokota J. 2002. MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer. Proc Natl Acad Sci USA 99:12269-12274.
26. Oliva MR, Ripoll F, Muniz P, Iradi A, Trullenque R, Valls V, Drehmer E, Saez GT. 1997. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 18:232-243.
27. Richards EJ, Elgin SC. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489-500.
28. Rustgi AK, Xu L, Pinney D, Sterner C, Beauchamp R, Schmidt S, Gusella JF, Ramesh V. 1995. Neurofibromatosis 2 gene in human colorectal cancer. Cancer Genet Cytogenet 84:24-26.
29. Schwarte-Waldhoff I, Klein S, Blass-Kampmann S, Hintelmann A, Eilert C, Dreschers S, Kalthoff H, Hahn SA, Schmiegel W. 1999. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18:3152-3158.
30. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J. 1994. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54:5643-5648.
31. Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J. 2004. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. Genes Chromosomes Cancer 40:146-151.
32. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206.
33. Yana I, Kurahashi H, Nakamori S, Kameyama M, Nakamura T, Takami M, Mori T, Takai S, Nishisho I. 1995. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int J Cancer 60:174-177.
34. Zhou CZ, Peng ZH, Zhang F, Qiu GQ, He L. 2002. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J Gastroenterol 8:668-673.